Define range intervals using parentheses.
E.g. C7H(10-14)O(0-4)

to
±
(example: 123 ± 1)

to
±

to
±
 

to
±
 
Search Hits Limit:
Single/Multi-component
Isotopically Labeled
Additional Filters

Found 53 results

Search term: MF = 'C_{25}H_{32}ClN_{5}OS'
123
IDStructureMolecular FormulaMolecular Weight# of Data Sources# of References# of PubMed# of RSC
22341
InChI=1/C25H32ClN5OS/c1-27-11-17-30(25(27)32)18-16-29-14-12-28(13-15-29)9-4-10-31-21-5-2-3-6-23(21)33-24-8-7-20(26)19-22(24)31/h2-3,5-8,19H,4,9-18H2,1H3
C25H32ClN5OS486.0725242640
3355595
InChI=1/C25H32ClN5OS/c1-2-3-4-7-14-30-24(20-10-12-21(26)13-11-20)27-31(25(30)33)19-28-15-17-29(18-16-28)22-8-5-6-9-23(22)32/h5-6,8-13,32H,2-4,7,14-19H2,1H3
C25H32ClN5OS486.0724811700
21728987

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C25H32ClN5OS/c1-18(29(5)6)23-27-28-24(31(23)21-14-12-20(26)13-15-21)33-17-22(32)30(25(2,3)4)16-19-10-8-7-9-11-19/h7-15,18H,16-17H2,1-6H3
C25H32ClN5OS486.07258600
22205286

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C25H32ClN5OS/c1-2-9-31-23-8-7-21(18-22(23)24(27-31)25(32)30-14-16-33-17-15-30)29-12-10-28(11-13-29)20-5-3-19(26)4-6-20/h2-6,21H,1,7-18H2
C25H32ClN5OS486.07258800
60551707

2 of 3 defined stereocentres - 2/3 defined
InChI=1/C25H32ClN5OS/c1-24(2,3)20-14-33-23(28-20)29-22(32)19-13-17(18-11-12-31(30-18)25(4,5)6)21(27-19)15-7-9-16(26)10-8-15/h7-12,14,17,19,21,27H,13H2,1-6H3,(H,28,29,32)/t17?,19-,21-/m0/s1
C25H32ClN5OS486.07254300
26375813

1 of 2 defined stereocentres - 1/2 defined
InChI=1/C25H32ClN5OS/c1-18-23-22(16-33-18)27-17-28-24(23)30-10-12-31(13-11-30)25(32)20(15-29-8-2-3-9-29)14-19-4-6-21(26)7-5-19/h4-7,17-18,20H,2-3,8-16H2,1H3/t18-,20?/m0/s1
C25H32ClN5OS486.07253300
58956861
InChI=1/C25H32ClN5OS/c1-16-20-15-23(33-25(20)31(29-16)19-6-4-3-5-7-19)24(32)28-18-8-9-22(21(26)14-18)30-12-10-17(27-2)11-13-30/h8-9,14-15,17,19,27H,3-7,10-13H2,1-2H3,(H,28,32)
C25H32ClN5OS486.07253300
22093799
InChI=1/C25H32ClN5OS/c1-18-19(2)33-25-23(18)24(27-22(28-25)17-30-12-14-32-15-13-30)31-9-3-8-29(10-11-31)16-20-4-6-21(26)7-5-20/h4-7H,3,8-17H2,1-2H3
C25H32ClN5OS486.07253100
4211553

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C25H32ClN5OS/c1-17-9-6-7-10-20(17)16-33-25-30-29-24(19(3)28-23(32)11-5-4-8-14-27)31(25)22-15-21(26)13-12-18(22)2/h6-7,9-10,12-13,15,19H,4-5,8,11,14,16,27H2,1-3H3,(H,28,32)
C25H32ClN5OS486.072483100
3228823
InChI=1/C25H32ClN5OS/c1-3-13-31(14-4-2)23-18-22(26)28-25(29-23)33-19-20-8-10-21(11-9-20)24(32)27-12-17-30-15-6-5-7-16-30/h3-4,8-11,18H,1-2,5-7,12-17,19H2,(H,27,32)
C25H32ClN5OS486.07253100
3240288

0 of 5 defined stereocentres - 0/5 defined
InChI=1/C25H32ClN5OS/c1-16-15-30(24-27-22(29-33-24)11-17-2-4-21(26)5-3-17)6-7-31(16)23(32)28-25-12-18-8-19(13-25)10-20(9-18)14-25/h2-5,16,18-20H,6-15H2,1H3,(H,28,32)
C25H32ClN5OS486.07252100
903766

Double-bond stereo
InChI=1/C25H32ClN5OS/c26-22-18-23(29-25(28-22)33-19-24(32)27-21-11-5-2-6-12-21)31-16-14-30(15-17-31)13-7-10-20-8-3-1-4-9-20/h1,3-4,7-10,18,21H,2,5-6,11-17,19H2,(H,27,32)
C25H32ClN5OS486.07252100
903779

Double-bond stereo
InChI=1/C25H32ClN5OS/c1-20-9-12-31(13-10-20)24(32)19-33-25-27-22(26)18-23(28-25)30-16-14-29(15-17-30)11-5-8-21-6-3-2-4-7-21/h2-8,18,20H,9-17,19H2,1H3
C25H32ClN5OS486.07252100
3594250

0 of 4 defined stereocentres - 0/4 defined
InChI=1/C25H32ClN5OS/c26-21-4-2-17(3-5-21)13-22-27-24(33-29-22)31-7-1-6-30(8-9-31)23(32)28-25-14-18-10-19(15-25)12-20(11-18)16-25/h2-5,18-20H,1,6-16H2,(H,28,32)
C25H32ClN5OS486.072482100
9671588

1 of 1 defined stereocentres - 1/1 defined
InChI=1/C25H32ClN5OS/c1-29-13-11-22(12-14-29)30-15-17-31(18-16-30)24(32)23(19-5-3-2-4-6-19)28-25(33)27-21-9-7-20(26)8-10-21/h2-10,22-23H,11-18H2,1H3,(H2,27,28,33)/t23-/m1/s1
C25H32ClN5OS486.07252100
9809229

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C25H32ClN5OS/c1-29-13-11-22(12-14-29)30-15-17-31(18-16-30)24(32)23(19-5-3-2-4-6-19)28-25(33)27-21-9-7-20(26)8-10-21/h2-10,22-23H,11-18H2,1H3,(H2,27,28,33)
C25H32ClN5OS486.07252100
127425766
InChI=1/C25H32ClN5OS/c1-16(2)32-23-14-20(18-6-9-27-10-7-18)17(3)13-22(23)30-25-29-15-21(26)24(31-25)28-11-8-19-5-4-12-33-19/h4-5,12-16,18,27H,6-11H2,1-3H3,(H2,28,29,30,31)
C25H32ClN5OS486.07252200
126628203

Double-bond stereo
InChI=1/C25H32ClN5OS/c1-6-30(7-2)21-12-10-20(11-13-21)17-27-31-23(28-29-25(31)33-5)9-8-14-32-22-15-18(3)24(26)19(4)16-22/h10-13,15-17H,6-9,14H2,1-5H3/b27-17+
C25H32ClN5OS486.07251100
127410890

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C25H31N5OS.ClH/c1-3-17-12-16(5-9-21(17)30-13-18-6-7-19(14-30)29-18)10-11-27-24(31)23-22(26)20-8-4-15(2)28-25(20)32-23;/h4-5,8-9,12,18-19,29H,3,6-7,10-11,13-14,26H2,1-2H3,(H,27,31);1H
C25H32ClN5OS486.07251100
8249669

Double-bond stereo
InChI=1/C25H31N5OS.ClH/c1-18-21-6-4-5-7-22(21)32-23(18)17-29(3)24(31)9-8-19-14-20(25(26)27-15-19)16-30-12-10-28(2)11-13-30;/h4-9,14-15H,10-13,16-17H2,1-3H3,(H2,26,27);1H/b9-8+;
C25H32ClN5OS486.07251100
123

Advertisement